"The two traditional means by which pharmaceutical marketers have
relied on for many, many years to encourage the uptake of new
pharmaceutical products -- direct-to-consumer (DTC) advertising and physician
marketing -- are about to change," warned Mark S. Senak, J.D., SVP,
Fleishman-Hillard and author of Eye On FDA Blog, in a presentation at the recent DTC
in the Era of Consumer Choice conference.
Senak summarized all
the possibly policy changes coming down the pike that will specifically
impart pharmaceutical marketing. He also suggests what the industry
should be doing to meet these challenges.
This article is summarizes Senak's presentation, which he later expanded upon in a YouTube video.
Topic headings include:
Read this article now. It's FREE...
- Changes Ahead for DTC Marketing
- Adverse Event Reporting Info in TV Ads
- Drug Safety
- Pricing Pressure
- Changing Communications Landscape
- Suggestions for Action
- Overcoming Regulatory Roadblocks
Download PDF file